Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: Associations by partner type and partner serostatus

Journal of Urban Health

Volumn 83, Issue 4, 2006, Pages 656-668

  Purcell, David W ^a,g   Mizuno, Yuko ^a   Metsch, Lisa R ^b   Garfein, Richard ^c   Tobin, Karin ^d   Knight, Kelly ^e   Latka, Mary H ^f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NEW YORK ACADEMY OF MEDICINE   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Heterosexual men; HIV positive; Injection drug users; Sexual risk

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; CLINICAL TRIAL; CONDOM; DEPRESSION; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTITUTION; RISK ASSESSMENT; SERODIAGNOSIS; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE;

ADULT; HETEROSEXUALITY; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; UNSAFE SEX;

EID: 33748372314     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-006-9066-1     Document Type: Article

References (35)

1. Janssen RS, Hotlgrave DR, Valdiserri RO, Shepherd M, Gayle HD, DeCock KM. The serostatus approach to fighting the HIV epidemic: prevention strategies for infection individuals. Am J Public Health. 2001;91:1019-1024.
2. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329-332.
3. Janssen RS, Valdiserri RO. HIV prevention in the United States: increasing emphasis on working with those living with HIV. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S119-S121.
4. Wolitski RJ, Parson JT, Gomez CA, the SUMIT Study Group. Lessons learned from the Seropositive Urban Men's Study (SUMS) and the Seropositive Urban Men's Intervention Trial (SUMIT). J Acquir Immune Defic Syndr. 2004;37(suppl 2):S101-S109.
5. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004 (Vol. 16). Department of Health and Human Services, Centers for Disease Control and Prevention; 2005: 32. Also available at: http://www.cdc.gov/hiv/ stats/hasrlink.htm.
6. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990-2002: use of a serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95:1439-1444.
7. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80:iii7-iii14.
8. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001;357:1397-1401.
9. Pinkerton SD, Abramson PR, Kalichman SC, Catz SL, Johnson-Masotti AP. Secondary HIV transmission rates in a mixed-gender sample. Int J STD AIDS. 2000;11:38-44.
10. Knight KR, Purcell DW, Dawson-Rose C, Halkitis PN, Gomez CA, & the Seropositive Urban Injectors Study Team. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. AIDS Educ Prev. 2005;17(suppl A):76-88.
11. Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings. AIDS. 2002;16:135-149.
12. Avants SK, Warburton LA, Hawkins KA, Margolin A. Continuation of high-risk behavior by HIV-positive drug users. Treatment implications. J Subst Abuse Treat. 2000;19:15-22.
13. Deren S, Beardsley M, Tortu S, Goldstein MF. HIV serostatus and changes in risk behaviors among drug injectors and crack users. AIDS Behav. 1998;2:171-176.
14. Kwiatkowski CF, Booth RE. HIV-Seropositive drug users and unprotected sex. AIDS Behav. 1998;2:151-159.
15. Metsch LR, McCoy CB, Lai S, Miles C. Continuing risk behaviors among HIV-seropositive chronic drug users in Miami, Florida. AIDS Behav. 1998;2:161-169.
16. Dolezal C, Meyer-Bahlburg HF, Liu X, et al. Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug users. Am J Drug Alcohol Abuse. 1999;25:281-303.
17. Avants SK, Warburton LA, Margolin A. How injection drug users coped with testing HIV-seropositive: implications for subsequent health-related behaviors. AIDS Educ Prev. 2001;13:207-218.
18. Bogart LM, Kral AH, Scott A, et al. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis. 2005;32:27-34.
19. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22:332-339.
20. Rosengard C, Anderson B, Stein MD. Intravenous drug users' HIV-risk behaviors with primary/other partners. Am J Drug Alcohol Abuse. 2004;30:225-236.
21. Purcell DW, Metsch L, Latka M, et al. Behavioral prevention trial with HIV-seropositive injection drug users: rationale and methods of the INSPIRE Study. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S110-S118.
22. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. The Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No. CD003255. DOI 10.1002/14651858.CD003255.
23. Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): Administration, Scoring, and Procedure Manual - 1. Baltimore, Maryland: John Wiley; 1982.
24. O'Leary A, Hoff CC, Purcell DW, Gomez, et al. What happened in the SUMIT trial? Mediation and behavior change. AIDS. 2005;19(Suppl 1):S111-S121.
25. Wolitski RJ, Gómez CA, Parsons J, Ambrose T, Remien R. HIV-seropositive men's perceived responsibility for preventing transmission of HIV to others. Poster presented at the XII International Conference on AIDS, Geneva, Switzerland, June 1998 (Poster no. 23361).
26. Mizuno Y, Kennedy M, Seals B, Myllyluoma J. Predictors of teens' attitudes toward condoms: gender difference in the effects of norms. J Appl Soc Psychol. 2000;30:1381-1395.
27. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, New Jersey: Prentice Hall; 1980.
28. Corby NH, Jamner MS, Wolitski RJ. Using the theory of planned behavior to predict intention to use condoms among male and female injection drug users. J Appl Soc Psychol. 1996;26:52-75.
29. Straus MA. Measuring intrafamily conflict and violence: the conflict tactics scales. J Marriage Fam. 1979;41:75-88.
30. Barrera MA. A method for assessing social support networks in community survey research. Connections. 1980;3:3-8.
31. Neter J, Wasserman W, Kutner MH. Applied Linear Statistical Models: Regression, Analysis of Variance, and Experimental Designs 2nd ed. Homewood, Illinois: R.D. Irwin; 1985.
32. O'Leary A. Guessing games: sex partner serostatus assumptions among HIV-positive gay and bisexual men. In: Halkitis PN, Gomez CA, Wolitski RJ, eds. HIV+ Sex: The Psychological and Interpersonal Dynamics of HIV-Seropositive Gay and Bisexual Men's Relationships. Washington, District of Columbia: American Psychological Association; 2005:121-132.
33. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, New York: Prentice Hall; 1986.
34. Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002;14:367-378.
35. Ghanem KG, Hutton HE, Zenilman JM, Zimba, R, Erbelding EJ. Audio computer-assisted self-interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm Infect. 2005;81:421-425.